Galen Partners
Overview
Galen Partners is a healthcare-focused growth equity investment firm. The firm invests in high-growth healthcare companies with revenues greater than $10 million and EBITDA between $0 and $9 million. They focus on healthcare information technology/outsourcing, medical devices and specialty pharmaceutical companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sharecare, Inc. | Jan 2012 | Growth Equity | Lead |
| CDx Diagnostics | Jul 2017 | Private Equity | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Galen Partners based?
Galen Partners is headquartered in Stamford, Connecticut, United States.
When was Galen Partners founded?
Galen Partners was founded in 1990.
How many portfolio companies does Galen Partners have?
Galen Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in Galen Partners's portfolio?
Portfolio companies visible on Caplight include Sharecare, Inc., CDx Diagnostics.
What was Galen Partners's most recent investment shown here?
Galen Partners's most recent investment in this portfolio sample was in CDx Diagnostics in 2017.
What sectors does Galen Partners focus on?
Galen Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Galen Partners focus on?
Galen Partners typically invests at the Early stage.
What is Galen Partners's AUM?
Galen Partners's assets under management are estimated between $250.0M and $500.0M.